Anticoagulant Therapy for Patients with Coronavirus Disease 2019: Urgent Need for Enhanced Awareness

Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a global pandemic. SARS-CoV-2 binds to the angiotensin-converting enzyme 2 receptor, which is abundantly expressed in vascular endothelial cells and damages these cells. Beside...

Descripción completa

Detalles Bibliográficos
Autores principales: Komiyama, Maki, Hasegawa, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Radcliffe Cardiology 2020
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479536/
https://www.ncbi.nlm.nih.gov/pubmed/32944087
http://dx.doi.org/10.15420/ecr.2020.24

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479536/
https://www.ncbi.nlm.nih.gov/pubmed/32944087
http://dx.doi.org/10.15420/ecr.2020.24

Ejemplares similares